Devonian Health Group Inc. (DVHGF)
USD 0.14
(8.49%)
USD 0.14
(8.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.59 Million CAD | -33.39% |
| 2022 | -3.44 Million CAD | -3.05% |
| 2021 | -3.34 Million CAD | 23.51% |
| 2020 | -4.37 Million CAD | -46.83% |
| 2019 | -2.97 Million CAD | 6.52% |
| 2018 | -3.18 Million CAD | 27.16% |
| 2017 | -4.37 Million CAD | -140.02% |
| 2016 | -1.82 Million CAD | -1948.14% |
| 2015 | -89.01 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -721.56 Thousand CAD | 16.42% |
| 2024 Q2 | -1.2 Million CAD | -66.31% |
| 2024 Q3 | -373.82 Thousand CAD | 68.85% |
| 2023 Q3 | -1.48 Million CAD | -41.02% |
| 2023 Q4 | -863.3 Thousand CAD | 41.91% |
| 2023 FY | -4.59 Million CAD | -33.39% |
| 2023 Q1 | -1.19 Million CAD | -53.16% |
| 2023 Q2 | -1.05 Million CAD | 11.93% |
| 2022 Q4 | -781.17 Thousand CAD | -12.37% |
| 2022 Q3 | -695.21 Thousand CAD | 38.13% |
| 2022 FY | -3.44 Million CAD | -3.05% |
| 2022 Q2 | -1.12 Million CAD | -32.47% |
| 2022 Q1 | -848.22 Thousand CAD | 4.52% |
| 2021 Q1 | -805.05 Thousand CAD | 44.85% |
| 2021 Q2 | -846.03 Thousand CAD | -5.09% |
| 2021 Q3 | -806.87 Thousand CAD | 4.63% |
| 2021 FY | -3.34 Million CAD | 23.51% |
| 2021 Q4 | -888.42 Thousand CAD | -10.11% |
| 2020 Q4 | -1.45 Million CAD | -85.08% |
| 2020 FY | -4.37 Million CAD | -46.83% |
| 2020 Q3 | -788.71 Thousand CAD | 34.5% |
| 2020 Q2 | -1.2 Million CAD | -30.55% |
| 2020 Q1 | -922.28 Thousand CAD | 1.26% |
| 2019 Q3 | -989.55 Thousand CAD | -147.87% |
| 2019 Q4 | -934.05 Thousand CAD | 5.61% |
| 2019 FY | -2.97 Million CAD | 6.52% |
| 2019 Q1 | -656.58 Thousand CAD | 43.49% |
| 2019 Q2 | -399.22 Thousand CAD | 39.2% |
| 2018 Q3 | -597.75 Thousand CAD | 23.72% |
| 2018 Q4 | -1.16 Million CAD | -94.36% |
| 2018 FY | -3.18 Million CAD | 27.16% |
| 2018 Q1 | -643.87 Thousand CAD | 76.76% |
| 2018 Q2 | -783.6 Thousand CAD | -21.7% |
| 2017 Q3 | -604.8 Thousand CAD | -1702.81% |
| 2017 FY | -4.37 Million CAD | -140.02% |
| 2017 Q2 | -33.54 Thousand CAD | -1026.53% |
| 2017 Q1 | -2978.00 CAD | 54.54% |
| 2017 Q4 | -2.77 Million CAD | -358.14% |
| 2016 Q4 | -6551.00 CAD | 82.3% |
| 2016 Q2 | -68.76 Thousand CAD | -21.97% |
| 2016 FY | -1.82 Million CAD | -1948.14% |
| 2016 Q1 | -56.38 Thousand CAD | -100.39% |
| 2016 Q3 | -37.02 Thousand CAD | 46.17% |
| 2015 Q2 | -13.37 Thousand CAD | 67.51% |
| 2015 Q4 | -28.13 Thousand CAD | -344.26% |
| 2015 FY | -89.01 Thousand CAD | 0.0% |
| 2015 Q1 | -41.16 Thousand CAD | 0.0% |
| 2015 Q3 | -6333.00 CAD | 52.65% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -3.81 Million USD | -20.44% |
| Skye Bioscience, Inc. | -37.64 Million USD | 87.782% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 107.062% |
| Nascent Biotech, Inc. | -2.08 Million USD | -120.321% |
| Qrons Inc. | -789.34 Thousand USD | -482.71% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1007.061% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 34.13% |
| BioStem Technologies, Inc. | -8.48 Million USD | 45.778% |
| Regen BioPharma, Inc. | 1.02 Million USD | 549.396% |
| CSL Limited | 2.64 Billion USD | 100.174% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 92.652% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 108.682% |
| Rebus Holdings, Inc. | -1.02 Million USD | -350.942% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -244.429% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -627.318% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 71.02% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 93.864% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 30.056% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1582.36% |
| SQZ Biotechnologies Company | -79.46 Million USD | 94.212% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -59.024% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -152.652% |
| Mesoblast Limited | -87.95 Million USD | 94.771% |
| Marizyme, Inc. | -65.34 Million USD | 92.961% |
| Genus plc | 7.9 Million USD | 158.223% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 57.77% |
| Pharming Group N.V. | -10.54 Million USD | 56.394% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -111.982% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -23.971% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 47.992% |
| ContraFect Corporation | -65.15 Million USD | 92.94% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 5.863% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -166.265% |
| IMV Inc. | -36.48 Million USD | 87.393% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 42.931% |
| MultiCell Technologies, Inc. | -380.07 USD | -1210099.963% |
| ONE Bio Corp. | 8.67 Million USD | 153.012% |
| Accustem Sciences Inc. | -3.74 Million USD | -22.773% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 91.102% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -262.993% |
| Q BioMed Inc. | -2.05 Million USD | -124.142% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -23.215% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -93.19% |
| Biomind Labs Inc. | -1.21 Million USD | -278.781% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 92.299% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -48.29% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 41.8% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -135.968% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -30613.188% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 20.932% |
| GB Sciences, Inc. | -1.36 Million USD | -237.79% |
| Alpha Cognition Inc. | -13.77 Million USD | 66.603% |
| HST Global, Inc. | -146.21 Thousand USD | -3045.891% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -162.12% |
| Halberd Corporation | -79.67 Thousand USD | -5672.889% |
| Enzolytics Inc. | -2.17 Million USD | -111.298% |
| Agentix Corp. | -1.37 Million USD | -234.709% |
| Resverlogix Corp. | -3.61 Million USD | -27.413% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -45.032% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 98.441% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 4793.477% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 166.424% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -15.772% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -51.996% |
| AVAX Technologies, Inc. | -6.41 Million USD | 28.284% |
| Zenith Capital Corp. | -10.59 Million USD | 56.591% |
| Genscript Biotech Corporation | -95.47 Million USD | 95.182% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -19690.065% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -10.943% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -7510.127% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -129.394% |
| Kadimastem Ltd | -3.3 Million USD | -39.07% |
| Helix BioMedix, Inc. | -1.05 Million USD | -335.545% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -942.123% |
| LadRx Corporation | 400.44 Thousand USD | 1248.63% |
| Cell Source, Inc. | -5.32 Million USD | 13.561% |
| Regen BioPharma, Inc. | 1.02 Million USD | 549.396% |
| NovAccess Global Inc. | -4.76 Million USD | 3.556% |
| Affymax, Inc. | -14.42 Million USD | 68.111% |
| Itoco Inc. | -1.86 Million USD | -146.101% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -3.536% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -175.591% |
| Mobile Lads Corp. | -2.26 Million USD | -103.226% |
| CytoDyn Inc. | -49.84 Million USD | 90.771% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -5719.856% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1916.248% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -388.525% |
| SYBLEU INC | -180.3 Thousand USD | -2451.029% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -185.205% |
| International Stem Cell Corporation | -131 Thousand USD | -3411.15% |
| Bioxytran, Inc. | -4.28 Million USD | -7.467% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -8375.101% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -81.785% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 90.432% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -117.578% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -489.023% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -45.19% |
| Neutra Corp. | -233.46 Thousand USD | -1870.148% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 77.332% |
| PureTech Health plc | -65.69 Million USD | 92.999% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 78.372% |
| IXICO plc | -1.17 Million USD | -290.459% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 53.666% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 91.949% |
| CSL Limited | 2.64 Billion USD | 100.174% |
| Cellectis S.A. | -103.17 Million USD | 95.542% |